share_log

華領醫藥-B：董事會召開日期

HUA MEDICINE-B: Date of Board Meeting

香港交易所 ·  Mar 18 16:30
Summary by Futu AI
華領醫藥-B（2552）宣布將於2024年3月28日舉行董事會會議，以考慮及通過包括2023年全年業績報告及末期股息建議在內的事項。該會議將由行政總裁兼執行董事陳力博士主持，並將處理其他相關事宜。此公告由公司於2024年3月18日在香港發出。
華領醫藥-B（2552）宣布將於2024年3月28日舉行董事會會議，以考慮及通過包括2023年全年業績報告及末期股息建議在內的事項。該會議將由行政總裁兼執行董事陳力博士主持，並將處理其他相關事宜。此公告由公司於2024年3月18日在香港發出。
Hualien Pharmaceutical-B (2552) announces that a Board meeting will be held on March 28, 2024 to consider and approve matters including the 2023 Annual Results Report and the Final Dividend Proposal. The meeting will be hosted by Dr. Chen Li, Chief Executive Officer and Executive Director, and will address other relevant matters. This announcement was made by the Company on 18 March 2024 in Hong Kong.
Hualien Pharmaceutical-B (2552) announces that a Board meeting will be held on March 28, 2024 to consider and approve matters including the 2023 Annual Results Report and the Final Dividend Proposal. The meeting will be hosted by Dr. Chen Li, Chief Executive Officer and Executive Director, and will address other relevant matters. This announcement was made by the Company on 18 March 2024 in Hong Kong.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.